United Kingdom · Investor

University of Oxford

Last cheque observed Oct 2026; 8 cheques on record.

Deploying nowInvestment firm

Series ASeries BSeries CMarketingSoftware

Deploying now
100%of best year2cheques in 12 months, 8 on record
Since the last cheque11days00hrs00min00sec
Median round$115MRounds led0 of 8Exits2 from the portfolioMostly inUnited Kingdom, 100%
Pitch University of Oxford

University of Oxford highlights

  1. 01

    2 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 50% of its rounds

  3. 03

    2 exits from the portfolio

What they do

Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Sectors
MarketingSoftware
Based in
Oxford, United Kingdom
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2026

    2 rounds

  2. Oct
    OMass TherapeuticsSeries C · GB · Jefferson Life Sciences$310MWith 12 others
  3. Jun
    RQ BioSeries A · GB · Frazier Life Sciences$115MWith 7 others
  4. 2018

    1 round

  5. Sept
    Oxford VRGB · Uktech$3.8MWith 4 others
  6. 2014

    2 rounds

  7. Sept
    AdaptimmuneSeries A · GB$104MWith 12 others
  8. Jun
    OxitecVenture · GB$10MWith 1 other
  9. 2013

    1 round

  10. Dec
    Chronos TherapeuticsGB · obn.org.uk$12MWith 3 others
  11. 2010

    2 rounds

  12. Jun
    Navetas Energy ManagementSeries B · GB · navetas.com$5.8MWith 2 others
  13. May
    Oxford ImmunotecSeries D · GB · onbiovc.com$26MWith 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

OxitecBought by Intrexon Corporation$160MAug 2015
Oxford ImmunotecListed$64MNov 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as University of Oxford. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies University of Oxford put money into.

On podcasts

1 episode naming University of Oxford in the title, and 4 more that mention it.

Mentioned in

Quick answers about University of Oxford

What does University of Oxford invest in?

University of Oxford invests most often at Series A and Series B (50% of the rounds on record), in sectors such as Marketing and Software.

How active is University of Oxford?

8 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026.

What has University of Oxford invested in recently?

Its most recent investments on record: OMass Therapeutics (Series C, Oct 2026), RQ Bio (Series A, Jun 2026) and Oxford VR (Undisclosed round, Sept 2018).

How big are University of Oxford's cheques?

The median round it joins is $115M.

Does University of Oxford lead rounds?

Rarely, if at all: none of its 8 investments on record names it as the lead.

Where does University of Oxford invest?

Most of the companies it backs are in the United Kingdom (100%).

Is University of Oxford investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

Who does University of Oxford invest alongside?

Most often Oxford Science Enterprises (3 rounds together), Forbion Capital Partners (2 rounds together) and Wellington Management (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it